State Street SPDR S&P Biotech ETF (XBI) Stock Price Today
Key Stats
- -Market Cap
- -Volume
- Broad Market / FactorSector
- $164.2852W High
- $85.1652W Low
- -Typical Hold Time
- -Enterprise Value
- -Div Yield
- -Trading Activity
Track State Street SPDR S&P Biotech ETF (XBI) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, State Street SPDR S&P Biotech ETF has traded between a low of $85.16 and a high of $164.28, highlighting its annual price range. Buy and sell State Street SPDR S&P Biotech ETF shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Most Recent News
Halper Sadeh LLC probes fairness of major mergers and sales for NEE, CRBG, RMAX, and APGE shareholders.
Halper Sadeh LLC is investigating whether shareholders of NextEra Energy (NEE), Corebridge Financial (CRBG), RE/MAX Holdings (RMAX), and Apogee Therapeutics (APGE) are receiving fair deals in their companies' proposed mergers or sales. The firm highl...
Law firm investigates if NextCure shareholders get a fair price in merger with Avere Therapeutics.
Halper Sadeh LLC is investigating the merger between NextCure, Inc. and Avere Therapeutics, Inc. to determine if NextCure's shareholders are receiving a fair price. The firm questions whether NextCure's board fulfilled their duties by securing the be...
AppFolio shares rise 2.46% amid insider sale and strong AI-driven growth outlook
AppFolio, Inc. saw its stock price increase by 2.46% to $179.90, outperforming major indices, driven by strong momentum and AI-focused growth strategies. Insider DUCA MAURICE J sold 3,500 shares worth $630,525 but still holds over 88,000 shares. Anal...
People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.